Enbrel, Actemra May Be Best Monotherapies for csDMARD-intolerant RA (CME/CE)

(MedPage Today) -- Meta-analysis found differences in effectiveness but not in harm across biologics
via Enbrel, Actemra May Be Best Monotherapies for csDMARD-intolerant RA (CME/CE)
by